Similar articles

• Research at the interface of industry, academia and regulatory science.

  Mattes WB, Walker EG, Abadie E, Sistare FD, Vonderscher J, Woodcock J, Woosley RL. Mattes WB, et al. Nat Biotechnol. 2010 May;28(5):432-3. doi: 10.1038/nbt0510-432. Nat Biotechnol. 2010. PMID: 20458309 No abstract available.
• Anticipating REMS.

  [No authors listed] [No authors listed] Nat Rev Drug Discov. 2008 Dec;7(12):963. doi: 10.1038/nrd2776. Nat Rev Drug Discov. 2008. PMID: 19043440 No abstract available.
• Biomarker qualification pilot process at the US Food and Drug Administration.

  Goodsaid F, Frueh F. Goodsaid F, et al. AAPS J. 2007 Mar 23;9(1):E105-8. doi: 10.1208/aapsj0901010. AAPS J. 2007. PMID: 17408233 Free PMC article.
• Adulteration of drugs and foods: compendial approaches to lowering risk.

  Abernethy DR, Sheehan C, Griffiths JC, Williams RL; United States Pharmacopeial Convention Council of Experts Excipients and Food Ingredient Expert Committees. Abernethy DR, et al. Clin Pharmacol Ther. 2009 Apr;85(4):444-7. doi: 10.1038/clpt.2008.88. Epub 2008 May 7. Clin Pharmacol Ther. 2009. PMID: 18463621 Review. No abstract available.
• Striving for standards in bioequivalence assessment: a review.

  Schulz HU, Steinijans VW. Schulz HU, et al. Int J Clin Pharmacol Ther Toxicol. 1991 Aug;29(8):293-8. Int J Clin Pharmacol Ther Toxicol. 1991. PMID: 1743802 Review. No abstract available.